This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose medication pens. The contract has a ceiling value of $41,193.09 and is a firm-fixed price Delivery Order, with an ultimate completion date of July 18, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, will be responsible for delivering this critical diabetes medication to support military treatment facilities and other government healthcare programs nationwide under this contract award. This order is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to $999,999,999, that enables the efficient procurement of a comprehensive range of pharmaceutical and medical supplies for the U.S. government.
Generated 10/16/24, 9:33 AM